BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6396475)

  • 1. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitazoxanide is active against Mycobacterium leprae.
    Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T
    PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
    Gelber RH; Siu P; Tsang M; Murray LP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
    Franzblau SG; Parrilla ML; Chan GP
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium leprae is naturally resistant to PA-824.
    Manjunatha UH; Lahiri R; Randhawa B; Dowd CS; Krahenbuhl JL; Barry CE
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3350-4. PubMed ID: 17005816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in leprosy.
    Matsuoka M
    Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
    McDermott-Lancaster RD; Banerjee DK
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy of experimental human leprosy (Myco. leprae) infection in the mouse foot pad.
    Gaugas JM
    Lepr Rev; 1967 Oct; 38(4):225-30. PubMed ID: 4864194
    [No Abstract]   [Full Text] [Related]  

  • 11. The activity of a thiadiazole on Mycobacterium leprae.
    Levy L
    Proc Soc Exp Biol Med; 1976 Oct; 153(1):34-6. PubMed ID: 792890
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 13. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
    Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
    Franzblau SG
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1232-4. PubMed ID: 1929269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
    Shen GH; Wu BD; Wu KM; Chen JH
    Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae.
    Randhawa B; Harris EB; Prabhakaran K
    J Antimicrob Chemother; 1999 Aug; 44(2):279-81. PubMed ID: 10473236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
    Franzblau SG; Takeda T; Nakamura M
    Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimal bactericidal dietary concentration of minocycline for Mycobacterium leprae-infected mice is very low and similar to its minimal inhibitory dietary concentration.
    Gelbert RH; Siu P; Tsang M; Murray LP
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):276-7. PubMed ID: 1522371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.